|
Acurian Announces Appointment of Dr. Richard "Rick" Malcolm As Company's New Chief Executive Officer
05/03/2005
Former CEO Mark Eisenach ends four-year tenure with record quarter and
registers 36th consecutive month with a new business award
Horsham, PA - Acurian, Inc., a full-service provider of site and patient
recruitment solutions, announced today that the company has appointed Richard
"Rick" Malcolm, Ph.D., as the company's new CEO, replacing Mark Eisenach who
concluded his four-year tenure as chief executive officer.
Dr. Malcolm was most recently the vice president of business development at
ICON Clinical Research, a large Contract Research Organization (CRO) with
offices worldwide, where he was responsible for North America.
"I'm exceptionally grateful for the opportunity to build upon Mark's notable
achievements at Acurian, and to do so with people who truly understand the value
of performance-driven services," stated Dr. Malcolm. "Based on my experiences
within the life sciences industry, I'm not surprised to see that patient
recruitment is still a sticking point in the research continuum. I'm pleased,
however, to see that Acurian has built and delivered several successful services
to address recruitment issues, and I look forward to building on the company's
recent growth."
At the end of 2004, Acurian was managing a company-record 35 projects. The
company subsequently ended the first quarter of 2005 by winning a record 18
project awards, including agreements with four new and six repeat customers.
"Clearly, Acurian is on the right track with regard to recruitment services
that resonate with its customers," continued Malcolm. "We closed business with
three of the top four pharma companies and had one of our highest proposal
quarters to date. That means we've established a healthy level of visibility in
the marketplace and, frankly, that is a great climate to step into as the new
chief executive officer."
Dr. Malcolm, who received his Ph.D. in Pharmacology at the University of
Southern California, has over 22 years experience in healthcare management,
including his four-year engagement at ICON, central laboratory general
management, product marketing experience at SmithKline Beecham Pharmaceuticals
(now GlaxoSmithKline), and executive leadership responsibilities at early stage
pharmaceutical companies.
About Acurian
Acurian is a leading full-service provider of clinical trial patient and
investigator recruitment solutions for the life sciences industry. Through its
proprietary patient panel, exclusive pharmacy partnerships, and centralized
screening platform, Acurian is able to identify, contact, prescreen, and refer
interested study candidates, as well as profile and recruit experienced
investigators, quickly and affordably. Since 1998, Acurian has helped accelerate
more than 100 clinical trials for over 30 pharmaceutical and biotechnology
companies, including 8 of the top 10 pharmaceutical companies in the world.
Acurian's investors include Euclid SR Partners, ProQuest Investments, JP Morgan
Partners, CDP Capital Technology Ventures, Flatiron Partners & Merck Capital
Ventures. Additional information about Acurian is available at www.acurian.com. |
